Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability

Cancer Research

Volumn 63, Issue 2, 2003, Pages 476-483

  Piboonniyom, Siribang on ^a,b,c   Duensing, Stefan ^b   Swilling, Nathan W ^b   Hasskarl, Jens ^b   Hinds, Philip W ^b   Müger, Karl ^b  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN P16; PROTEIN P53; RAS PROTEIN; TELOMERASE; VIRUS PROTEIN;

ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL IMMORTALIZATION; CELL MUTANT; CELL POPULATION; CELL SELECTION; CELL SURVIVAL; CELL TRANSFORMATION; CENTROSOME; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; KERATINOCYTE; MICROSATELLITE INSTABILITY; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; TUMOR CELL; TUMOR SUPPRESSOR GENE; WART VIRUS;

CELL TRANSFORMATION, NEOPLASTIC; CENTROSOME; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; DNA-BINDING PROTEINS; GINGIVA; HUMANS; KERATINOCYTES; ONCOGENE PROTEINS, VIRAL; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037439799     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. American Cancer Society Cancer Facts & Figures 2002. Atlanta, GA: American Cancer Society. 2002.
2. Fernandez-Martinez, J. A., Ruiz-Avila, I., Bravo, M., Ramos, M. C., Martinez-Lara, I., Urquia, M., and Gonzaler-Moles, M. A. Some histopathological and clinical correlations in oral squamous cell carcinoma. Bull. Group. Int. Rech. Sci. Stomatol. Odontol., 38: 11-15, 1995.
3. Gillison, M. L., Koch, W. M., Capone, R. B., Spafford, M., Westra, W. H., Wu, L., Zahurak, M. L., Daniel, R. W., Viglione, M., Symer, D. E., Shah, K. V., and Sidransky, D. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. (Bethesda), 92: 709-720, 2000.
4. Jefferies, S., and Foulkes, W. D. Genetic mechanisms in squamous cell carcinoma of the head and neck. Oral Oncol., 37: 115-126, 2001.
5. Shay, J. W. Telomerase in human development and cancer. J. Cell. Physiol., 173: 266-270, 1997.
6. Wright, W. E., Pereira-Smith, O. M., and Shay, J. W. Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol. Cell. Biol., 9: 3088-3092, 1989.
7. Shay, J. W., Pereira-Smith, O. M., and Wright, W. E. A role for both RB and p53 in the regulation of human cellular senescence. Exp. Cell Res., 196: 33-39, 1991.
8. Greider, C. W. Telomere length regulation. Annu. Rev. Biochem., 65: 337-365, 1996.
9. van Steensel, B., Smogorzewska, A., and de Lange, T. TRF2 protects human telomeres from end-to-end fusions. Cell, 92: 401-413, 1998.
10. Karlseder, J., Broccoli, D., Dai, Y., Hardy, S., and de Lange, T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science (Wash. DC), 283: 1321-1325, 1999.
11. Artandi, S. E., Chang, S., Lee, S. L., Alson, S., Gottlieb, G. J., Chin, L., and DePinho, R. A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature (Lond.), 406: 641-645, 2000.
12. Morin, G. B. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell, 59: 521-529, 1989.
13. Yu, G. L., Bradley, J. D., Attardi, L. D., and Blackburn, E. H. In vivo alteration of telomere sequences and senescence caused by mutated Tetrahymena telomerase RNAs. Nature (Lond.), 344: 126-132, 1990.
14. Weinrich, S. L., Pruzan, R., Ma, L., Ouellette, M., Tesmer, V. M., Holt, S. E., Bodnar, A. G., Lichtsteiner, S., Kim, N. W., Trager, J. B., Taylor, R. D., Carlos, R., Andrews, W. H., Wright, W. E., Shay, J. W., Harley, C. B., and Morin, G. B. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat. Genet., 17: 498-502, 1997.
15. Bodnar, A. G., Ouellette, M., Frolkis, M., Holt, S. E., Chiu, C. P., Morin, G. B., Harley, C. B., Shay, J. W., Lichtsteiner, S., and Wright, W. E. Extension of life-span by introduction of telomerase into normal human cells. Science (Wash. DC), 279: 349-352, 1998.
16. Shay, J. W., and Bacchetti, S. A survey of telomerase activity in human cancer. Eur. J. Cancer, 33: 787-791, 1997.
17. Mutirangura, A., Supiyaphun, P., Trirekapan, S., Sriuranpong, V., Sakuntabhai, A., Yenrudi, S., and Voravud, N. Telomerase activity in oral leukoplakia and head and neck squamous cell carcinoma. Cancer Res., 56: 3530-3533, 1996.
18. Mao, L., El-Naggar, A. K., Fan, Y. H., Lee, J. S., Lippman, S. M., Kayser, S., Lotan, R., and Hong, W. K. Telomerase activity in head and neck squamous cell carcinoma and adjacent tissues. Cancer Res., 56: 5600-5604, 1996.
19. Salisbury, J. L., Whitehead, C. M., Lingle, W. L., and Barrett, S. L. Centrosomes and cancer. Biol. Cell, 91: 451-460, 1999.
20. Saunders, W. S., Shuster, M., Huang, X., Gharaibeh, B., Enyenihi, A. H., Petersen, I., and Gollin, S. M. Chromosomal instability and cytoskeletal defects in oral cancer cells. Proc. Natl. Acad. Sci. USA, 97: 303-308, 2000.
21. Duensing, S., Lee, L. Y., Duensing, A., Basile, J., Piboonniyom, S., Gonzalez, S., Crum, C. P., and Munger, K. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc. Natl. Acad. Sci. USA, 97: 10002-10007, 2000.
22. Duensing, S., Duensing, A., Crum, C. P., and Munger, K. Human papillomavirus type 16 E7 oncoprotein-induced abnormal centrosome synthesis is an early event in the evolving malignant phenotype. Cancer Res., 61: 2356-2360, 2001.
23. Munger, K., Basile, J. R., Duensing, S., Eichten, A., Gonzalez, S. L., Grace, M., and Zacny, V. L. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene, 20: 7888-7898, 2001.
24. Krisanaprakornkit, S., Weinberg, A., Perez, C. N., and Dale, B. A. Expression of the peptide antibiotic human β-defensin 1 in cultured gingival epithelial cells and gingival tissue. Infect. Immun., 66: 4222-4228, 1998.
25. Piboonniyom, S., Timmermann, S., Hinds, P., and Munger, K. Aberrations in the MTS1 tumor suppressor locus in oral squamous cell carcinoma lines preferentially affect the INK4A gene and result in increased cdk6 activity. Oral Oncol., 38: 179-186, 2002.
26. INK4a-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell. Biol., 20: 1436-1447, 2000.
27. Yang, Z., Delgado, R., Xu, L., Todd, R. F., Nabel, E. G., Sanchez, A., and Nabel, G. J. Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science (Wash. DC), 279: 1034-1037, 1998.
28. Halbert, C. L., Demers, W., and Galloway, D. A. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol., 65: 473-478, 1991.
29. Miller, A. D., and Rosman, G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques, 7: 980-982, 984-986, 989-990, 1989.
30. ink4a in oral squamous cell carcinoma lines by 5-aza-2′-deoxycytidine treatment induces a senescence-like state. Oncogene, 17: 3445-3453, 1998.
31. Ausubel, F. M., Brent, R., Kingston, R. E., Morre, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. Short Protocols in Molecular Biology. 2nd ed. New York: Green Publishing Associates and John Wiley & Sons, 1992.
32. Kamb, A., Shattuck-Eidens, D., Eeles, R., Liu, Q., Gruis, N. A., Ding, W., Hussey, C., Tran, T., Miki, Y., Weaver-Feldhaus, J., et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat. Genet., 8: 23-26, 1994.
33. Zhang, S. Y., Kleinszanto, A. J. P., Sauter, E. R., Shafarenko, M., Mitsunaga, S., Nobori, T., Carson, D. A., Ridge, J. A., and Goodrow, T. L. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Res., 54: 5050-5053, 1994.
34. Herman, J. G., Graff, J. R., Myohanen, S., Nelkin, B. D., and Baylin, S. B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA, 93: 9821-9826, 1996.
35. Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., Pereira-Smith, O., Peacocke, M., and Campisi, J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA, 92: 9363-9367, 1995.
36. Boyer, S. N., Wazer, D. E., and Band, V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res., 56: 4620-4624, 1996.
37. 1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J. Virol., 71: 2905-2912, 1997.
38. Kiyono, T., Foster, S. A., Koop, J. I., McDougall, J. K., Galloway, D. A., and Klingelhutz, A. J. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature (Lond.), 396: 84-88, 1998.
39. Foster, S. A., Wong, D. J., Barrett, M. T., and Galloway, D. A. Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol. Cell. Biol., 18: 1793-1801, 1998.
40. Medema, R. H., Herrera, R. E., Lam, F., and Weinberg, R. A. Growth suppression by p16ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA, 92: 6289-6293, 1995.
41. Hahn, W. C., and Weinberg, R. A. Modelling the molecular circuitry of cancer. Nat. Rev. Cancer, 2: 331-341, 2002.
42. Sedman, S. A., Hubbert, N. L., Vass, W. C., Lowy, D. R., and Schiller, J. T. Mutant p53 can substitute for human papillomavirus type 16 E6 in immortalization of human keratinocytes but does not have E6-associated trans-activation or transforming activity. J. Virol., 66: 4201-4208, 1992.
43. DiRenzo, J., Signoretti, S., Nakamura, N., Rivera-Gonzalez, R., Sellers, W., Loda, M., and Brown, M. Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line. Cancer Res., 62: 89-98, 2002.
44. Rheinwald, J. G., Hahn, W. C., Ramsey, M. R., Wu, J. Y., Guo, Z., Tsao, H., De Luca, M., Catricala, C., and O'Toole, K. M. A two-stage, p16INK4A- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status. Mol. Cell. Biol., 22: 5157-5172, 2002.
45. Duensing, S., and Munger, K. Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability. Oncogene, 21: 6241-6248, 2002.
46. Hayflick, L. Human cells and aging. Sci. Am., 218, 32-37, 1968.
47. Loughran, O., Clark, L. J., Bond, J., Baker, A., Berry, I. J., Edington, K. G., Ly, I. S., Simmons, R., Haw, R., Black, D. M., Newbold, R. F., and Parkinson, E. K. Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene, 14: 1955-1964, 1997.
48. Allsopp, R. C., Chang, E., Kashefi-Aazam, M., Rogaev, E. I., Piatyszek, M. A., Shay, J. W., and Harley, C. B. Telomere shortening is associated with cell division in vitro and in vivo. Exp. Cell Res., 220: 194-200, 1995.
49. Morris, M., Hepburn, P., and Wynford-Thomas, D. Sequential extension of proliferative lifespan in human fibroblasts induced by over-expression of CDK4 or 6 and loss of p53 function. Oncogene, 21: 4277-4288, 2002.
50. Alani, R. M., Young, A. Z., and Shifflett, C. B. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc. Natl. Acad. Sci. USA, 98: 7812-7816, 2001.
51. Timmermann, S., Hinds, P., and Münger, K. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines. Cell Growth Differ., 8: 361-370, 1997.
52. Parry, D., Bates, S., Mann, D. J., and Peters, G. Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16(INK4/MTS1) tumour suppressor gene product. EMBO J., 14: 503-511, 1995.
53. Reznikoff, C. A., Yeager, T. R., Belair, C. D., Savelieva, E., Puthenveettil, J. A., and Stadler, W. M. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res., 56: 2886-2890, 1996.
54. INK4A as a specific marker for dysplastic and neoplastic epithelial cell of the cervix uteri. Int. J. Cancer, 92: 276-284, 2001.
55. Münger, K. Werness, B. A., Dyson, N., Phelps, W. C., Harlow, E., and Howley, P. M. Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product. EMBO J., 8: 4099-4105, 1989.
56. Gonzalez, S. L., Stremlau, M., He, X., Basile, J. R., and Münger, K. Degradation of the retinoblastoma tumor suppressor by the human papillomavirus type 16 E7 oncoprotein is important for functional inactivation and is separable from proteasomal degradation of E7. J. Virol., 75: 7583-7591, 2001.